Modulation of arabinosyladenine metabolism by 2'-deoxycoformycin in the therapy of human acute leukemia.
D000243:Adenosine Deaminase / Q000097:blood*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003070:Coformycin / Q000031:analogs & derivatives / Q000627:therapeutic use*; D004912:Erythrocytes / Q000378:metabolism*; D006801:Humans; D007700:Kinetics; D007938:Leukemia / Q000097:blood / Q000188:drug therapy*; D009700:Nucleoside Deaminases / Q000097:blood*; D015649:Pentostatin; D012263:Ribonucleosides / Q000627:therapeutic use*; D014740:Vidarabine / Q000097:blood*
D000970:Antineoplastic Agents; D012263:Ribonucleosides; D003070:Coformycin; D015649:Pentostatin; D009700:Nucleoside Deaminases; D000243:Adenosine Deaminase; D014740:Vidarabine